Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  Based on 30,749,272 shares of the Issuer's common stock outstanding as of November 7, 2024, as reported in the Quarterly Report on Form 10-Q filed by the Issuer on November 12, 2024.


SCHEDULE 13G




Comment for Type of Reporting Person:  Based on 30,749,272 shares of the Issuer's common stock outstanding as of November 7, 2024, as reported in the Quarterly Report on Form 10-Q filed by the Issuer on November 12, 2024.


SCHEDULE 13G




Comment for Type of Reporting Person:  Based on 30,749,272 shares of the Issuer's common stock outstanding as of November 7, 2024, as reported in the Quarterly Report on Form 10-Q filed by the Issuer on November 12, 2024.


SCHEDULE 13G




Comment for Type of Reporting Person:  Based on 30,749,272 shares of the Issuer's common stock outstanding as of November 7, 2024, as reported in the Quarterly Report on Form 10-Q filed by the Issuer on November 12, 2024.


SCHEDULE 13G



 
Cetus Capital VI, L.P.
 
Signature:/s/ Robert E. Davis
Name/Title:Littlejohn Associates VI, L.P., its general partner
Date:02/12/2025
 
Littlejohn Opportunities Master Fund LP
 
Signature:/s/ Robert E. Davis
Name/Title:Littlejohn Opportunities GP LLC, its general partner
Date:02/12/2025
 
OFM II, L.P.
 
Signature:/s/ Robert E. Davis
Name/Title:Littlejohn Opportunities GP II, LLC, its general partner
Date:02/12/2025
 
VSS Fund, LP
 
Signature:/s/ Robert E. Davis
Name/Title:Littlejohn Opportunities GP LLC, its general partner
Date:02/12/2025
Exhibit Information

Exhibit A: Joint Filing Agreement.